Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Thursday 6 August 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 451 (CSE: $GTII.C) (CSE: $TGIF.C) (TSXV: $EVE.V) (CSE: $ISH.C)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 451 (CSE: $GTII.C) (CSE: $TGIF.C) (TSXV: $EVE.V) (CSE: $ISH.C)

 

Delta, Kelowna, BC, August 6, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/080620-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/08061GTI-TGIF-EVE-ISH.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ and Essence retail stores, and Cookies, a leading North American cannabis lifestyle brand, today announced an exclusive partnership to open Cookies on the Strip in Las Vegas, the first Cookies store in Nevada. Cookies on the Strip will sell the acclaimed portfolio of Cookies, Lemonnade, Runtz, Minntz, Collins Ave, Run The Jewels and Grandiflora products in the brand’s signature retail environment and is expected to open in the first quarter 2021, subject to customary regulatory approvals.

 

Based in the Bay Area, Cookies' Founder and CEO Berner is a prolific rapper and entrepreneur along with his partner, Jai, a highly respected cannabis cultivator and breeder.

"We have been working on Las Vegas for a very long time and we wanted to do it right which is why we chose to partner with Green Thumb,” said Cookies Founder and Chief Executive Officer Berner. “Everybody comes to Vegas, whether it be for a wedding, bachelor or bachelorette party, birthday, anniversary or just to celebrate in general. Vegas has always focused on spoiling the visitor with five-star restaurants, hotels and entertainment. With a store right on the Strip and our cultivation partners dialed in, as well as an exclusive five-star menu dedicated just to the Nevada market, we are more than ready for Vegas. It won’t be hard to find us either, we have a very special design for our store."

 

The Essence and Rise™ retail locations in Las Vegas, Henderson, Spanish Springs and Carson City will also offer Cookies products including popular favorites such as London Pound Cake 75, Gary Payton and Cereal Milk.

 

Green Thumb Founder and Chief Executive Officer Ben Kovler said: “We have long believed that cannabis brands that offer a consistent and authentic customer experience is key to winning in the industry – and Berner has created a phenomenal brand with a loyal following. This partnership allows us to explore bringing the unique Cookies experience to market in a must-visit destination for Las Vegas visitors and residents.”

 

The Essence store located at 2308 South Las Vegas Boulevard will be rebranded to Cookies on the Strip. The store will remain open during the transition. Green Thumb currently owns and operates seven stores in the state, five of which are in the Las Vegas area, and manufactures and distributes its branded products including Cannabiotix, Dogwalkers, incredibles and Rythm in Nevada. The company has licenses to open six more retail stores in the state.

 

“Las Vegas remains an exciting growth opportunity for our business with ongoing strong demand for cannabis products,” Kovler noted. “This is a unique opportunity to collaborate with Berner and his visionary team in one of the most popular tourist spots in the world.”

 

1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), a vertically-integrated cannabis consumer packaged goods company, announced the addition of top brand Five Star Extracts to its select roster of licensed partners in Nevada. The Company's subsidiary, Alternative Medicine Association LC ("AMA"), signed a licensing agreement with California-based Five Star Group, LLC, ("Five Star Extracts" or "Five Star") for the cultivation, manufacture and sale of Five Star Extracts branded products in Nevada for a one-year term.

 

The Company's newest partnership reaffirms AMA's position as a top producer of cannabis concentrates in Nevada. AMA's expertise in the field has been developed over several years as one of the first cultivation and production licensees in the state.  AMA will manufacture Five Star products, including its exclusive flavored Double Shot line and flavored cannabis tinctures. Under the licensing agreement, AMA will manufacture, distribute and sell the licensed products, ensuring compliance with Nevada regulations as well as third-party laboratory testing and certification.  The licensed products have already received the approval from the newly formed State of Nevada Cannabis Compliance Board (CCB).

 

Five Star Extracts are some of the highest quality THC products in the market. Five Star follows strict proprietary extraction procedures to achieve clarity and potency for a smooth cannabis product that stands above the rest. "We are excited to work with a team who shares the same high standards, passion and pride for crafting top quality cannabis products," stated Mr. Jordan Stroum, Director of Sales for 1933 Industries' brands and brand partners. "Five Star brings a differentiated approach to their product offerings with an innovative suite of products that are easy to consume, discreet and can be taken on the go.

The Double Shot line is a fast-acting beverage containing 20mg of THC in a variety of flavors and their cannabis-infused tincture beverage enhancers with mix and match flavours are unique to our brand offerings. We are excited to assist Five Star grow its brand in Nevada."

 

Mr. Jason Winkler, CEO & Co-Founder of Five Star Extracts, stated, "Five Star is very excited to expand the brands footprint in additional states with trusted and like-minded partners such as 1933. We are looking forward to having our Five Star quality product lineup and executing the same marketing initiatives we pride ourselves on within Nevada."

 

 

Eve & Co Incorporated (TSXV: EVE) (OTCQX: EEVVF) announced that its wholly-owned subsidiary, Natural MedCo Ltd., has signed a supply agreement with Colio Estate Wines, one of Canada’s leading wineries and the company behind the top-selling domestic flavoured wine beverage brand, Girls’ Night Out1 on August 5, 2020. 

 

The supply agreement contemplates developing a premium cannabis-infused wine-based beverage for distribution by Eve & Co and licensing for the Girls’ Night Out brand. The term of the license agreement is for an initial three-year period with a two-year option in favour of NMC and contemplates licensing royalties for the cannabis-infused beverage to enter the adult-use market in 2020.

 

 “We are very excited to be working with Colio and the tremendous team behind the Girls’ Night Out brand. The combination of Colio’s expertise with our high-quality cannabis extract allows us to provide consumers with a new cannabis-infused beverage which aligns very well with our female-oriented vision,” said Melinda Rombouts, President and Chief Executive Officer of Eve & Co.

 

Jim Clark, President and CEO of Colio noted that “Colio is delighted to be working with Eve & Co to produce a new cannabis-infused beverage that builds on the success of the Girls’ Night Out brand at satisfying the tastes and palates of female wine aficionados or connoisseurs.

 

Inner Spirit Holdings Ltd. (CSE: ISH), a Canadian company that has established a national network of Spiritleaf retail cannabis stores, today announced additional Spiritleaf store openings and the continued expansion of its retail cannabis store network in Alberta and Ontario. The Company also announced it has surpassed the one million customers served milestone for 2020 during the month of July. It recorded its highest-ever monthly customer count in July as well with 205,000 guests served.

 

"We're very pleased to continue our expansion of the Spiritleaf brand into additional communities. We have aggressive growth plans and we're staying focused on adding outlets to serve more Canadians. We have numerous franchise partners either working through licensing or constructing their stores at this time. Our franchise model is extremely effective as we partner with local entrepreneurs and enable them to invest their capital, share their passion and knowledge of cannabis with customers, and contribute to the success of the Spiritleaf brand. We're proud of every single customer we've served this year as that reflects the care and the attention we bring to the shopping experience at our stores for new visitors as well as our loyal repeat customers," said Darren Bondar, President and CEO of Inner Spirit.

The Company celebrated the opening of its 55th Spiritleaf location on July 24 with a franchised store in Calgary, Alberta's Southland community located at the Brick Plaza on Macleod Trail. The Company has a franchise location in Fish Creek Village in Calgary fully built and awaiting final licensing and has conditionally secured five additional franchise locations in Calgary and two additional corporate store locations in Edmonton in anticipation of the Alberta Gaming, Liquor & Cannabis increasing the licensing cap to over 45 permitted stores per operator this fall.

 

In Ontario, Spiritleaf franchised stores opened in the suburban community of Stittsville near Ottawa on July 25 and in London's Masonville neighbourhood on July 27. A corporate-owned store in Nepean just south of Ottawa opened on July 29 bringing the total number of Spiritleaf stores operating to 58. These stores follow on Spiritleaf stores in Toronto, Ottawa, Guelph and Kingston. In total, the Company has nine Spiritleaf stores serving customers in Canada's most populous province and an additional 17 locations under various phases of development.

 

Additional store locations have been conditionally secured in British Columbia, Saskatchewan, Manitoba, and Newfoundland and Labrador helping to solidify Spiritleaf as Canada's only coast-to-coast retailer. Please visit www.spiritleaf.ca for information on store opening times and operating hours.

 

Due to the COVID-19 pandemic, all Spiritleaf stores are operating with enhanced customer service processes to ensure the safety of employees and customers. Spiritleaf's Select & Collect service enables customers to pre-shop and order online prior to pick-up. Customers can also connect with their local Spiritleaf store through the Spiritleaf Collective customer benefits program to further streamline and individualize the shopping experience. The fast-growing Collective program now has over 85,000 members.

 

To acknowledge the support from these members, the Company has been running a virtual Spirit Bus Tour across Canada this summer to spread peace, love and harmony. The tour is making "stops" at each Spiritleaf store where Spiritleaf Collective members can access exclusive promotions and special edition festival swag. Bus tickets are available in-store or by email or text for Collective members and no purchase is required. Please visit www.spiritbustour.ca for tour dates and details.

 

An updated version of the Company's investor presentation as well as a video interview with CEO Darren Bondar on BNN Bloomberg have been added to www.innerspiritholdings.com/invest/. The Company expects to file its Financial Statements and Management's Discussion and Analysis for the quarter ended June 30, 2020 on or about August 24, 2020.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 


Wednesday 5 August 2020

Investorideas.com - Cannabis Deal Tracker: Investment and M&Amp;Amp;Amp;A Activity in the Cannabis Industry July 27th - July 31st, 2020

Investorideas.com - Cannabis Deal Tracker: Investment and M&Amp;Amp;Amp;A Activity in the Cannabis Industry July 27th - July 31st, 2020

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 450 (CSE: $CXXI.C) (NASDAQ: $VFF) (TSXV: $RLV.V) (TSXV: $WMD.V)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 450 (CSE: $CXXI.C) (NASDAQ: $VFF) (TSXV: $RLV.V) (TSXV: $WMD.V)

 


Delta, Kelowna, BC, August 5, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/080520-StocksToWatch.mp3

 

Read this in full at http://www.investorideas.com/news/2020/cannabis-potcasts/08051CXX-VFF-RLV-WMD.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

C21 Investments Inc. (CSE: CXXI) (OTCQB: CXXIF) announced record revenue at its Nevada dispensaries for its second quarter ("Q2" ending July 31, 2020) as well as for the month of July 2020.

 

Nevada Retail Highlights:

       Q2 retail revenue sets record for a quarter, surpassing the previous high in Q3 of last year

       July sets a monthly revenue record; first month over $3 million at Silver State dispensaries and best month ever at the Fernley dispensary

       $98.5k retail revenue run rate per day in July; previous record of $96.5k in June 2020

       $63 average ticket size in Q2

       Phantom Farms flower continues as Silver State's top SKU – 13 of the top 25 SKUs are the Company's Oregon brands

 

Company CEO and President, Sonny Newman: "We are very pleased with the record Q2 and July performance at our Nevada dispensaries which is a testament to the dedication of our team. We are proud to be celebrating our fifth anniversary as Nevada's first licensed dispensary. Despite beginning the quarter under state-mandated delivery-only sales, we responded quickly and began operating three complementary sales channels in May as restrictions eased. Our strong and loyal customer base continues to mitigate the impact of the pandemic on our Nevada business. While both dispensaries are performing exceptionally well, our Fernley dispensary continues to significantly exceed expectations with July recording its best month of sales to date."

 

"In the second quarter C21 has continued to optimize its Oregon operations. As of June, several non-core Oregon assets are subject to third-party management agreements and nearing the completion of sale, which will generate cash, and reduce costs and liabilities from mid-June onwards. With operations streamlined in Oregon, and robust revenue and EBITDA margins at our Silver State dispensaries, C21 is working to deepen its presence in Nevada as we continue to make progress in establishing our debt facility."

 

"As reported in our recent year-end financials, our Nevada dispensaries generated an average of approximately $16 million in revenue and $6 million in adjusted EBITDA per dispensary. With the ability to replicate and scale both our profitable dispensary model, and our vertically integrated operations in Nevada, and with 80% of our cultivation and production facility still untapped, we expect to build on Q2's record retail revenue and enhance shareholder value moving forward," said Mr. Newman.

 

Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF) announced that it has executed a binding agreement to acquire 6.6% of Australia-based Altum International Pty Ltd, one of the Asia-Pacific's leading cannabinoid platforms, subject to the completion of certain conditions, which are expected to be finalized in the next several weeks.  Under the terms of the Agreement, Village Farms has the option to increase its ownership in Altum on similar terms.

 

Altum's mission is to bring the life-changing benefits of cannabinoids (with focus on CBD) to consumers across the Asia-Pacific region through a comprehensive platform for the large-scale importation, distribution and marketing of CBD, composed of three channels, with an overriding focus on regulatory compliance for each specific country market:

       Proprietary Consumer Brands – Fully-owned consumer brands, currently consisting of Felix and Co (www.felixandco.com), Kind Cannabis and tsubomi;

       Commercial Inputs – A range of cost-competitive, compliant and effective premium CBD ingredients through its LIFE brand (www.lifecbd.asia), designed for seamless addition to foods, beverages, cosmetics and other consumer packaged goods; and,

       Retail – Retail sales and educational and experiential stores for both Altum and partner products.

        

Altum has initially focused on opportunities in Hong Kong, which has one of the most progressive attitudes and regulatory regimes for CBD in the Asia-Pacific region.  It has already launched a broad range of CBD products under its Felix and Co brand to very favorable customer feedback and strong initial sales traction.  In its Commercial Input channel, Altum is supplying craft brewers for CBD-infused beer, as well as market-wide coffee chains and juice bars for beverages and edibles, and is in advanced discussions for supply agreements to provide inputs for a range of other products, including pet food, cosmetics, and spa products for hotels.  In June 2020, Altum opened a boutique café and retail concept store in Hong Kong named Found – Asia's first dedicated CBD consumer outlet. Altum plans to pursue its business strategy throughout the Asia-Pacific region, including but not limited to Greater China, Japan, South Korea, Thailand, Australia and New Zealand, with the goal to be commercially active in at least three additional countries in the next 12 months.

 

Altum is also pursuing high-THC medical cannabis opportunities in Australia and New Zealand, where medicinal cannabis is already legal in both countries, and intends to pursue recreational cannabis opportunities in each of those countries should legalization occur.  Altum is well positioned to capitalise on the medicinal cannabis opportunity in New Zealand via a 49% interest in Kariki Pharma Limited (www.karikipharma.com). Kariki is a New Zealand-domiciled medicinal cannabis company focused on creating a suite of pharmaceutical quality medicinal cannabis for New Zealand, Australian, Asian, and European patients and export markets.  New Zealand intends to hold a national referendum on the legalization of the recreational use of cannabis on 19 September 2020.

 

"On the heels of our recent investment in the Netherlands, our partnership with Altum represents another meaningful step to leverage our three decades of experience in vertically integrated, intensive agriculture, as well as our cannabis success in Canada, for international CBD and cannabis opportunities," said Michael DeGiglio, CEO, Village Farms International. "Village Farms is at a place where, with well-established North American operations, continuously refined and enhanced for optimized performance and growth, we are able to turn our attention to strategic, early-stage international opportunities where CBD and cannabis are being legalized in our pursuit of well-researched capital allocation for the generation of outsized, long-term returns."

 

"With approximately 4.5 billion people – more than four times that of the U.S., Canada and Europe combined – the Asia-Pacific market represents one such sizeable but nascent opportunity, with the addressable market for cannabis alone forecast to reach US$10 billion by 2024.  Altum is an outstanding organization at the very forefront of the emerging CBD industry in the Asia-Pacific region and represents a capital efficient means by which to participate in this significant opportunity, as well as the legal medical, and potentially the legal recreational, cannabis markets in Australia and New Zealand."

 

Relevium Technologies Inc. (TSXV: RLV) (OTC: RLLVF) announced that it has secured licenced a patented science based nutraceutical formulation that addresses major points of viral invasion, replication and toxicities develop by Dr. Dana F. Flavin, an internationally-recognized expert in immune modulation and the prevention and treatment of viruses and cancer.

 

The patented formulation developed by Dr. Dana F. Flavin, which will be marketed under the Company’s Bioganix brand, was developed to work with multiple pathways to combat viral infections, including COVID-19, by increasing the antiviral defense while decreasing the replication and toxicity of the virus.

 

According to Dr. Dana Flavin, the most important aspect of a multiple pathway approach is synergy – a process in which some substances cooperate to reach a combined effect that is greater than the sum of their separate effect. Synergy is not only important in the development of a specific effective formulation, but also as an adjunct to conventional drug therapy.

 

The patented formulation was designed the address viral infections through a synergistic interaction of several natural and GRAS ingredients that amplify effect of ingredients working with enhanced supportive mechanisms, which show greater efficacies based on their expansion of the biochemical processes and pharmacological activities.

 

Based on research about specific ingredients, the following natural substances offer important benefits in the prevention and treatment of viral infection such as COVID-19. When combined, their qualities are amplified for effectiveness.

 

N-acetylcysteine (NAC) added for its ability proven in clinical studies to increase lymphocytes that contain interferon. Lymphocytes are often suppressed in viral infections like COVID-19. These cells that release interferon are part of the Th1 lymphocytes important for their antiviral activity. One of the mechanisms in this lymphocyte suppression is the generation of a gas, nitric oxide. This gas comes from an enzyme, nitric oxide synthase, and is elevated in viral infections. NAC binds to this gas and allows the movement of these lymphocytes back into the blood stream and an increased antiviral activity of these Th1 lymphocytes. Additionally, NAC increases the endogenous anti-inflammatory factor, glutathione, in the lung tissue.

 

Olive Leaf Extract and Licorice Root added for their ability proven in clinical studies to increase the release of interferon. One of the most important mechanisms in viral defense is to increase interferon, which works directly against virus replication and/or invasion. Many natural substances increase the release of interferon. Combined, olive leaf extract and licorice root are the most effective natural substances to increase this release of interferon from the lymphocytes. Olive leaf contains essential substances like polyphenols including oleuropein, which increases the release of interferon lymphocytes. Olive leaf also increases the absolute numbers of the CD8+ and natural killer cells to improve the defense against viral infections. Additionally, licorice root with its glycyrrhinic acid, increases the release of interferon. Licorice root has been used for hundreds of years to fight upper respiratory viruses.

 

Zinc added for its ability proven in clinical studies to increase the efficacy of interferon. Zinc is a known trace element that is imperative for the immune system where it improves the host response to many infections and plays an important role in the homeostasis of the immune system. In the cases of viral infection, it increases the interferon efficacy to a multiple as much as 10-fold as well as having direct antiviral activities. Zinc supplementation decreases the morbidity of lower respiratory tract infections in pediatric patients in the developing world. In respiratory syncytial virus infections, for example, zinc prevents the replication of the virus. With rhinoviruses, zinc appears to inhibit the direct binding of the virus. Zinc also inhibits the replication of human immunodeficiency virus type I (HIV-1); herpes simplex virus (HSV); 0020vaccinia virus; and polioviruses.

 

Elderberry, Vitamin C, and Lemon Balm added for their ability proven in clinical studies to inhibit viral replication. One of the important nuclear transcription factors involved in viral replication in coronavirus infections is nuclear factor kappa B (NFKappaB). This key transcription factor activates numerous genes involved in cellular immune response and inflammation. Many studies have shown that NF-kappa B plays an important role in the pathogenesis of lung diseases, and therefore, is important to inhibit this nuclear factor in preventing and/or supporting patients with COVID-19. There are many antioxidants that inhibit this important factor in viral replication. The most important ones are Vitamin C, lemon balm and elderberry -- natural substances that inhibit viral replication through their inhibition of NFKappaB. Additional mechanisms that fight against viral infections include direct and indirect immune activation, inhibition of viral replication, and even down regulating toxic oxygen radicals involved in cell damage from viruses.

 

Cherry Extract, Rose Hips and Nicotinamide added for their ability proven in clinical studies to inhibit the oxygen radicals. The damage caused by oxygen radicals in viral infections has been known for many years. The major enzymes involved in this toxicity are xanthine oxidase (XO), NADPH oxidase and inducible nitric oxide synthase (iNOS). The superoxide radical, generated from XO and/or NADPH OX combine with the nitric oxide generated from the iNOS to form the toxic product, peroxynitrite. Viruses, including coronaviruses, are toxic via this pathway. These radicals are massively destructive to tissues where they are generated. In the case of COVID-19, this involves predominantly the lung tissue, causing a decrease in oxygen transfer leading to major lung toxicity and hypoxia in multiple organs.

 

The Company has partnered with the licensor, a Canadian company engaged in the research and development of proprietary Nutraceutical products, Intellectual properties and other related formulas for the health and wellness, nutraceutical industries and the general public, to develop a strategy for brand development, messaging and retail distribution.

Licensor has granted the Company an initial exclusive license for the UNITED STATES, GERMANY and COLOMBIA to use the Licensed Product and the Licensor Intellectual Property to manufacture, have manufactured and sell the Licensed Product, provided that the Licensed Product is manufactured in accordance with the specifications and quality standards submitted or approved by Licensor.

 

Licensor grants licenses and rights to the IP Rights and Marks through a base revenue share per unit sold of three dollars. The Company has also agreed that the licensor will be working in partnership with the Company to engage a third party or parties  at it sole discretion , time and place for the purpose of marketing, selling and promoting of such licensed products through major retail chains where in this case that such collaboration will result in a profit margin sharing.

 

CEO of Relevium Aurelio Useche stated, “We are extremely excited to have secured the exclusive license for this 100% natural synergistic and multi-pathway patented formulation, which we will be launching in the market over the next months. This is a major addition to the CleanCare product portfolio adding prevention and immunity support to the Bioganix line of trusted nutraceuticals”

 

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) announced that it has entered into an exclusive licensing, manufacturing and distribution agreement with premium, U.S.-based cannabis wellness house, MM Technology Holdings, LLC, owner of Mary’s Brands, and the acclaimed product line, Mary’s Medicinals.

 

Under the terms of the Agreement, as Mary’s sole Canadian partner, WeedMD will manufacture a suite of Mary’s Medicinals’ products in-house with its own input biomass at its state-of-the-art extraction hub CX Industries later this year. WeedMD will also market, sell and distribute Mary’s Medicinals’ products across Canada’s provincial adult-use and direct-to-consumer medical channels as it looks to expand new cannabis offerings to address an underserved wellness and medical market segment. Widely recognized for its innovative portfolio of delivery methods, Mary’s suite of cannabis products includes transdermal gels and patches and topicals.      

“As we move into the next level of product development, it’s imperative that we strategically partner with established brands that share our core values and Mary's Brands offers a superior product line that is backed by a team truly dedicated to ensuring the quality, integrity and efficacy of its product offerings,” said Angelo Tsebelis, CEO of WeedMD. “We’re proud to be selected as Mary’s exclusive Canadian producer and distributor. With our cultivation platform and CX extraction operations fully ramped-up, there's the added pride of developing these renowned products in-house as we expand with new cannabis formats into a lucrative, yet underserved consumer segment.”

 

“We’re thrilled to be partnering with WeedMD and its CX extraction team as we execute on our long-term growth strategy to expand the Mary’s Medicinals brand into Canada,” said Jacques Panis, CEO of Mary’s Brands. “Our continued desire to innovate on additional product offerings makes this partnership fitting as we look to collaborate with a strong, experienced team that brings unparalleled expertise in cultivation and extraction along with a proven ability to capture unique, next-level distribution channels.”

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 


Tuesday 4 August 2020

Investorideas.com - Cannabis Stock News: Cannabis One Holdings Inc. (CSE: CBIS) Announces Additional Officer and Director Updates Associated with its Recently Announced Strategic Rebranding to INDVR Brands Inc.

Investorideas.com - Cannabis Stock News: Cannabis One Holdings Inc. (CSE: CBIS) Announces Additional Officer and Director Updates Associated with its Recently Announced Strategic Rebranding to INDVR Brands Inc.

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 449 - Interview with Matt Markiewicz, Managing Director of the Cannabis ETF (NYSE: $THCX)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 449 - Interview with Matt Markiewicz, Managing Director of the Cannabis ETF (NYSE: $THCX)

 


Delta, Kelowna, BC, August 4, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/080420-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/08041Interview-Matt-Markiewicz-THCX.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast Investorideas interviews Matt Markiewicz, the managing director of The Cannabis ETF (NYSE: THCX), where we discussed some of the portfolio’s recent earnings reports, how the last few months of COVID-19 have impacted the ETF as well as expectations moving forward.

 

Markiewicz commented on the last few months and how COVID-19 impacted the industry, specifically focussing on how while the industry remains federally illegal in the U.S. it was also deemed essential in most states where it is legalized.

 

“I think we’ve started to see some optimism come back into the sector and I think that’s shown through in the stock prices. After hitting that low in mid-March the ETF is up close to 60% since then, and that’s not uncommon for many of the other ETF’s. We have seen a nice rebound and we seem to have stabilized here in that the ETF’s and the stocks seem to be trading sideways a bit. We have also seen a bit of a decrease in volatility in the sector but it is summer and you do have less market participants involved and we will still have to see how things play out into the fall.”

 

Markiewicz continued by discussing how this relates to some of the recent earnings reports.

 

“In terms of earnings. This (last week) was one of the first big weeks for Cannabis earnings reports, we just had Aphria (NASDDAQ: APHA) and Scotts Miracle Gro (NYSE: SMG). The week of August 10th, up in Canada, Canopy Growth (NYSE:CGC) and Tilray (NASDAQ: TLRY)  report and then next week (this week) we have Cronos and GW Pharmaceutical earnings as well. In the US on the week of August 10th we get earnings reports from Colombia Care, Harvest, Acreage, Trulieve and Greenthumb, so that’s going to be a major focus week for cannabis in general. Who knows we might even have a renewed media focus on cannabis earnings, which probably should be pretty encouraging based on the sales levels we’ve seen in the past few months.”

 

Markiewicz then went on to discuss in more detail Scotts recent earnings in more depth.

 

“For Scotts Miracle Gro most people associate it with golf courses and fertilizer for your house, but this is a company that is an ancillary play on the growth of the US cannabis industry and the fact that its listed on the NYSE means that many investors can buy the issue. It’s been holding in our portfolio since we launched last July and is the 6th largest holding in the fund, just under 6%. Scotts reported an absolute blockbuster quarter. Their division, Hawthorne Gardening, where there are over 40 brands that are leveraged towards the US cannabis industry which saw sales grow 72% year on year in the third quarter. Well above what all analysts thought they’d deliver. To me there is also a very positive readthrough from another company called GrowGeneration Corp. (NASDAQ:GRWG), who is one of the largest US hydroponics stores, and GrowGeneration sells a lot of the brands that are under the Hawthorne Gardening banner. So I think it’s an extremely strong readthrough and a name that investors should keep an eye on. You have to remember that there aren’t many stocks that have leverage to the US cannabis industry that can be purchased by US institutional investors. Only about 9% of the publicly traded cannabis market cap is owned by US institutional investors.”

 

Markiewicz went on to discuss some of the other upcoming earnings reports and what market expectations are so far as well as what investors should be looking for both in the US and Canada over the next few months.

 

“After seeing Organigram’s and Aphria’s earnings I’m not expecting any overly positive surprises from any of these LP’s yet to report. The narrative at the beginning of the year was it’s going to be a second half story once we see “2.0” sales kick in and newer products hitting shelves. Obviously COVID has slowed that down but the narrative continues to be more optimistic towards the second half of the year. At what point though is the patience from investors going to wear thin if that second half story doesn’t materialize. I think it’s very much a “put up or shut up” time when the third quarter rolls around, for the Canadian cannabis industry in particular.”

 

Markiewicz went on to discuss in more detail some of the expectations for the US industry over the next few months as well as the ETF’s views on the still very nascent psychedelic industry.

 

The Cannabis ETF was constructed to make investing in cannabis easier by helping investors get exposure to a basket of stocks that are expected to benefit from growth of the hemp and legal marijuana industries. To find out more visit their website at https://thcxetf.com/.

 

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 


Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : Weeding through the Winners in Canna...